Small animal positron emission tomography imaging and in vivo studies of atherosclerosis

Research output: Contribution to journal › Journal article › Research › peer-review

Standard

Small animal positron emission tomography imaging and in vivo studies of atherosclerosis. / Hag, Anne Mette Fisker; Ripa, Rasmus Sejersten; Pedersen, Sune Folke; Bodholdt, Rasmus Poul; Kjaer, Andreas.

In: Clinical Physiology and Functional Imaging, Vol. 33, No. 3, 05.2013, p. 173-85.

Research output: Contribution to journal › Journal article › Research › peer-review

Harvard

Hag, AMF, Ripa, RS, Pedersen, SF, Bodholdt, RP & Kjaer, A 2013, 'Small animal positron emission tomography imaging and in vivo studies of atherosclerosis', Clinical Physiology and Functional Imaging, vol. 33, no. 3, pp. 173-85. https://doi.org/10.1111/cpf.12017

APA

Hag, A. M. F., Ripa, R. S., Pedersen, S. F., Bodholdt, R. P., & Kjaer, A. (2013). Small animal positron emission tomography imaging and in vivo studies of atherosclerosis. Clinical Physiology and Functional Imaging, 33(3), 173-85. https://doi.org/10.1111/cpf.12017

Vancouver

Hag AMF, Ripa RS, Pedersen SF, Bodholdt RP, Kjaer A. Small animal positron emission tomography imaging and in vivo studies of atherosclerosis. Clinical Physiology and Functional Imaging. 2013 May;33(3):173-85. https://doi.org/10.1111/cpf.12017

Author

Hag, Anne Mette Fisker ; Ripa, Rasmus Sejersten ; Pedersen, Sune Folke ; Bodholdt, Rasmus Poul ; Kjaer, Andreas. / Small animal positron emission tomography imaging and in vivo studies of atherosclerosis. In: Clinical Physiology and Functional Imaging. 2013 ; Vol. 33, No. 3. pp. 173-85.

Bibtex

@article{4c54823a0b2b47539335f511a289b5cd,
title = "Small animal positron emission tomography imaging and in vivo studies of atherosclerosis",
abstract = "Atherosclerosis is a growing health challenge globally, and despite our knowledge of the disease has increased over the last couple of decades, many unanswered questions remain. As molecular imaging can be used to visualize, characterize and measure biological processes at the molecular and cellular levels in living systems, this technology represents an opportunity to investigate some of these questions in vivo. In addition, molecular imaging may be translated into clinical use and eventually pave the way for more personalized treatment regimes in patients. Here, we review the current knowledge obtained from in vivo positron emission tomography studies of atherosclerosis performed in small animals.",
author = "Hag, {Anne Mette Fisker} and Ripa, {Rasmus Sejersten} and Pedersen, {Sune Folke} and Bodholdt, {Rasmus Poul} and Andreas Kjaer",
note = "{\textcopyright} 2013 The Authors Clinical Physiology and Functional Imaging {\textcopyright} 2013 Scandinavian Society of Clinical Physiology and Nuclear Medicine.",
year = "2013",
month = may,
doi = "10.1111/cpf.12017",
language = "English",
volume = "33",
pages = "173--85",
journal = "Clinical Physiology and Functional Imaging",
issn = "1475-0961",
publisher = "Wiley-Blackwell",
number = "3",

}

RIS

TY - JOUR

T1 - Small animal positron emission tomography imaging and in vivo studies of atherosclerosis

AU - Hag, Anne Mette Fisker

AU - Ripa, Rasmus Sejersten

AU - Pedersen, Sune Folke

AU - Bodholdt, Rasmus Poul

AU - Kjaer, Andreas

N1 - © 2013 The Authors Clinical Physiology and Functional Imaging © 2013 Scandinavian Society of Clinical Physiology and Nuclear Medicine.

PY - 2013/5

Y1 - 2013/5

N2 - Atherosclerosis is a growing health challenge globally, and despite our knowledge of the disease has increased over the last couple of decades, many unanswered questions remain. As molecular imaging can be used to visualize, characterize and measure biological processes at the molecular and cellular levels in living systems, this technology represents an opportunity to investigate some of these questions in vivo. In addition, molecular imaging may be translated into clinical use and eventually pave the way for more personalized treatment regimes in patients. Here, we review the current knowledge obtained from in vivo positron emission tomography studies of atherosclerosis performed in small animals.

AB - Atherosclerosis is a growing health challenge globally, and despite our knowledge of the disease has increased over the last couple of decades, many unanswered questions remain. As molecular imaging can be used to visualize, characterize and measure biological processes at the molecular and cellular levels in living systems, this technology represents an opportunity to investigate some of these questions in vivo. In addition, molecular imaging may be translated into clinical use and eventually pave the way for more personalized treatment regimes in patients. Here, we review the current knowledge obtained from in vivo positron emission tomography studies of atherosclerosis performed in small animals.

U2 - 10.1111/cpf.12017

DO - 10.1111/cpf.12017

M3 - Journal article

C2 - 23522010

VL - 33

SP - 173

EP - 185

JO - Clinical Physiology and Functional Imaging

JF - Clinical Physiology and Functional Imaging

SN - 1475-0961

IS - 3

ER -

ID: 45692014